Search
Dr Shiroma De Silva-Minor

Dr Shiroma De Silva-Minor

Clinical oncology 04190426

 

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Breast

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Dr Shiroma De Silva-Minor is a Consultant Clinical Oncologist. She was appointed as an NHS Consultant in 2008 till 2024, at The Oxford University Hospitals NHS Trust. Shiroma specialises inOncology treatments for breast cancers.

Shiroma graduated from University of Wales College of Medicine, Cardiff in 1995 and became a Member of the Royal College of Physicians (UK) in 1999. Having chosen to specialise in Clinical Oncology, she trained as a specialist registrar in London, working at nationally renowned cancer centres including UCL The Middlesex Hospital, The Royal Free and The Royal Marsden Hospital. In 2003, Shiroma became a Fellow of the Royal College of Radiologists (UK) in 2003.

During a fellowship in Head and Neck Radiation Oncology at the prestigious Princess Margaret Hospital, Toronto, Shiroma was awarded the Prize for Academic Excellence by the institution and The University of Toronto for her research into the use of PET CT for identifying head and neck tumours for radiotherapy treatment.
Shiroma has presented her research at international conferences including The Annual meeting of the Canadian Association of Radiation Oncologists (CARO) in British Columbia and the American Society for Therapeutic Radiology and Oncology (ASTRO) in Colorado and in Philadelphia and at the European Society of Therapeutic Radiation and Oncology (ESTRO).

As a Clinical Oncologist, Shiroma oversees the whole non-surgical aspects of a patients journey from genetic testing, counselling; through to treatments including chemotherapy, external beam radiotherapy (including partial breast treatment), Intraoperative radiotherapy, PARP inhibitors, CDK4/6 inhibitors, clinical trials.

Shiroma is interested in research and is currently collaborating on a metanalysis with the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) to bring together the research on radiotherapy clinical trials to better understand how to optimally treat breast cancer patients with radiotherapy.

Shiroma is a member of the Advisory Board on Cancer in Pregnancy (ABCIP), an international panel of experts in managing breast cancer in pregnancy.

Shiroma has been an expert member of the Breast Cancer Committee for the National Institute of Health and Care Excellence (NICE), involved in updating the national guidelines on breast cancer management.

Shiroma is a passionate advocate for empowering her patients to be involved in their management decisions. Treatment is completely bespoke to individual patients, their specific tumour subtype, taking into consideration the individual's beliefs, wishes and personal circumstances.

Areas of interest

Breast oncology specialising in Male Breast cancers, Triple negative breast cancers, Breast cancer in Pregnancy, Her 2 positive cancers,
Radiotherapy;
Chemotherapy;
Clinical Trials;
Intraoperative radiotherapy;
External beam radiotherapy;
PARP inhibitors;
CDK4/6 inhibitors
Liquid biopsis/ genomic profiling of breast cancers
Genetic counselling and testing

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)

    GenesisCare, Oxford (>50) Cromwell Hospital (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    GenesisCare, Oxford (5-50)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (5-50)

    GenesisCare, Oxford (5-50)

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

    GenesisCare, Oxford (5-50)

  • X3590

    Intravenous infusion (as sole procedure) - (5-50)

  • X6773

    Preparation for simple radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

    GenesisCare, Oxford (5-50)

  • X0001

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (1-5)

    GenesisCare, Oxford (1-5)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (1-5)

  • Show All (11 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.